Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs
Open Access
- 16 May 2019
- journal article
- research article
- Published by Springer Nature in BMC Medical Genomics
- Vol. 12 (1) , 62
Abstract
Pancreatic and biliary tract cancer (PC and BTC, respectively) are difficult to diagnose because of their clinical characteristics; however, recent studies suggest that serum microRNAs (miRNAs) might be the key to developing more efficient diagnostic methods for these cancers. We analysed the genome-wide expression of serum miRNAs in PC and BTC patients to identify novel biomarker candidates using high-throughput sequencing and experimentally validated miRNAs on clinical samples. Statistical and classification analysis of the serum miRNA-expression profiles of 55 patient samples showed distinguishable patterns between cancer patients and healthy controls; however, we were unable to distinguish the two cancers. We found that three of the highest performing miRNAs were capable of distinguishing cancer patients from controls, with an accuracy of 92.7%. Additionally, dysregulation of these three cancer-specific miRNAs was demonstrated in an independent sample group by quantitative reverse transcription polymerase chain reaction. These results suggested three candidate serum miRNAs (mir-744-5p, mir-409-3p, and mir-128-3p) as potential biomarkers for PC and BTC diagnosis.Keywords
Funding Information
- Ministry of Trade, Industry and Energy (10040174)
This publication has 57 references indexed in Scilit:
- MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancersOncogene, 2011
- Salivary Transcriptomic Biomarkers for Detection of Resectable Pancreatic CancerGastroenterology, 2010
- Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profilesMetabolomics, 2009
- RNA-Seq: a revolutionary tool for transcriptomicsNature Reviews Genetics, 2009
- Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences of the United States of America, 2008
- A reciprocal repression between ZEB1 and members of the miR‐200 family promotes EMT and invasion in cancer cellsEMBO Reports, 2008
- Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor developmentProceedings of the National Academy of Sciences, 2007
- Diagnosis of pancreatic cancerHPB, 2006
- MicroRNA expression profiles classify human cancersNature, 2005
- A 10‐year experience in the management of gallbladder cancerHPB, 2003